. Sanaz Zangeneh; . Mitra Savabi-Esfahani; . Fariba Taleghani; . Mohammad Reza Sharbafchi; . Mehrdad Salehi
Volume 12, Issue 5 , June 2022, , Pages 1-6
Abstract
BACKGROUND: Women undergoing breast cancer treatment, especially those of reproductive age,experience sexual health challenges. The aim of this study is to design an interventional ...
Read More
BACKGROUND: Women undergoing breast cancer treatment, especially those of reproductive age,experience sexual health challenges. The aim of this study is to design an interventional programfor promoting the sexual health of women undergoing breast cancer treatment.MATERIALS AND METHODS: This is a mixed qualitative‑quantitative exploratory study consistingof four phases. In the first phase, the needs and strategies for promoting sexual health of Iranianwomen with breast cancer in Isfahan city will be identified through a qualitative study. The patients willbe selected using purposive sampling method and the data will be collected through semi‑structuredinterviews. In the second phase of the study, the relevant literature will be reviewed. In the third phase,the initial version of the program will be designed based on the results of qualitative study and reviewof literature, the appropriate strategies are prioritized by the members of the panel of experts, andthen, the final interventional program is prepared. In the fourth phase, the designed interventionalprogram will be conducted as a quasi‑experimental study in two groups of intervention and controland the effectiveness of the program on sexual quality of life, sexual satisfaction, and sexual functionof women undergoing breast cancer treatment will be evaluated. The type of the intervention will beselected based on the results of the previous phases and the opinion of the expert panel.CONCLUSIONS: The results of this study are expected to contribute to the design of an interventionalprogram based on the needs of women undergoing breast cancer treatment and promote health andmeet the sexual health needs of breast cancer patients.